文献速递新发突发、热带与寄生虫病

一种血液RNA特征可在年轻登革热患者入院时识别重症疾病

A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival.
PubMed 文献 · J Infect Dis · 2018-01-01

该研究在4至22岁柬埔寨登革热患者中前瞻性采集入院时外周血单核细胞,分析42份二次感染登革热血清型1患者的转录组图谱,识别出18基因特征用于检测重症登革热,灵敏度和特异度分别为0.93和0.67,验证队列AUC分别为0.85和0.83。

要点

  • 18基因特征检测二次感染患者入院时重症登革热的灵敏度为0.93,特异度为0.67。
  • 该特征在PBMC和全血验证数据集中的经验AUC分别为0.85和0.83。
  • 该特征基因可为重症登革热发病机制提供新见解。

核心结论

  • 该18基因特征可在二次感染患者入院时检测重症登革热。
  • 其特征基因可为重症登革热发病机制提供新见解。

研究设计与样本

  • 前瞻性研究,纳入柬埔寨4至22岁登革热患者。
  • 入院时获取外周血单核细胞(PBMC)。
  • 分析42份二次感染登革热血清型1患者的转录组图谱。
  • 采用新的特征发现方法控制纳入基因数量并捕捉转录本浓度与严重程度之间的非线性关系。
  • 在22份来自本队列额外患者的PBMC样本和32份来自独立队列的全血样本中验证该特征。

主要发现

  • 识别出18基因特征用于检测二次感染患者入院时重症登革热,灵敏度为0.93(95% CI,.82-.98),特异度为0.67(95% CI,.53-.80),AUC为0.86(95% CI,.75-.97)。
  • 验证时,该特征在PBMC数据集的经验AUC为0.85(95% CI,.69-1.00),在全血数据集的经验AUC为0.83(95% CI,.68-.98)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early detection of severe dengue can improve patient care and survival. To date, no reliable single-gene biomarker exists. We hypothesized that robust multigene signatures exist. METHODS: We performed a prospective study on Cambodian dengue patients aged 4 to 22 years. Peripheral blood mononuclear cells (PBMCs) were obtained at hospital admission. We analyzed 42 transcriptomic profiles of patients with secondary dengue infected with dengue serotype 1. Our novel signature discovery approach controls the number of included genes and captures nonlinear relationships between transcript concentrations and severity. We evaluated the signature on secondary cases infected with different serotypes using 2 datasets: 22 PBMC samples from additional patients in our cohort and 32 whole blood samples from an independent cohort. RESULTS: We identified an 18-gene signature for detecting severe dengue in patients with secondary infection upon hospital admission with a sensitivity of 0.93 (95% confidence interval [CI], .82-.98), specificity of 0.67 (95% CI, .53-.80), and area under the receiver operating characteristic curve (AUC) of 0.86 (95% CI, .75-.97). At validation, the signature had empirical AUCs of 0.85 (95% CI, .69-1.00) and 0.83 (95% CI, .68-.98) for the PBMCs and whole blood datasets, respectively. CONCLUSIONS: The signature could detect severe dengue in secondary-infected patients upon hospital admission. Its genes offer new insights into the pathogenesis of severe dengue.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Nikolayeva I, Bost P, Casademont I, et al. A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival. J Infect Dis. 2018. PMID: 29490079. doi:10.1093/infdis/jiy086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。